Introduction
Ca 2þ -induced Ca 2þ release (CICR) is a fundamental cellular mechanism to generate and amplify intracellular Ca 2þ signals. 1, 2 In healthy heart cells, CICR is operated between L-type Ca 2þ channels (LCCs) in the cell membrane/T-tubules and ryanodine receptor (RyR) Ca 2þ release channels in the sarcoplasmic reticulum (SR). 3, 4 The RyR-mediated SR Ca 2þ release determines the pace and strength of myocardial contraction. Intuitively, CICR is by nature a positive feedback, and would be expected to operate in an explosive all-or-none manner. However, the existence of solitary RyR Ca 2þ release events, Ca 2þ sparks, 5 suggests that global positive feedback among RyRs is effectively avoided such that the CICR is actually modulated precisely in a graded manner. 6 This paradox has been explained by the local control model, in which RyRs are under nanoscopic 'private' control by adjacent LCCs within their native Ca 2þ release unit (CRU). Although regenerative CICR may still exist within a CRU, 7, 8 a CRU does not respond to Ca 2þ signals propagating from neighbouring CRUs. [9] [10] [11] This scenario is supported by ultrastructural studies, which show that the RyR-residing junctional SRs meet with cell membrane/T-tubules at a distance ($15 nm) much shorter than the inter-CRU distance. 12 To avoid inter-CRU crosstalk, the RyR sensitivity to Ca 2þ triggers must be limited within a certain range. The 12.6-kd FK506-binding protein (FKBP12.6, also known as calstabin-2) is a cardiac RyR accessory protein 13, 14 proposed to stabilize RyR Ca 2þ release. 15, 16 However, the role of FKBP12.6 in RyR function has been highly controversial. 17 In lipid bilayer experiments, single RyRs from FKBP12.6-knockout mice or treated with rapamycin/FK506 to dissociate FKBP12.6 are found to have increased open probability and partial opening/sub-conductance. [18] [19] [20] However, single-channel experiments from other labs have shown that the removal of FKBP12.6 from RyRs neither alters channel activity nor prompts sub-conductance. 13, 21, 22 While it has been demonstrated that FKBP12.6 dissociation synergistically enhances the RyR response to protein kinase A (PKA)-mediated phosphorylation, 15, 23, 24 contrary evidence has shown that the PKA-induced RyR regulation does not depend on FKBP12.6. [25] [26] [27] In intact cardiomyocytes, some reports have shown that FK506 treatment or FKBP12.6 dissociation increases the spontaneous Ca 2þ spark frequency and Ca 2þ transient amplitude. 20, 28, 29 FKBP12.6 knockout mice develop severe arrhythmia that leads to sudden cardiac death during exercise. 24 By contrast, a later report has shown that FKBP12.6 knockout neither promotes spontaneous RyR activity nor causes ventricular arrhythmias under stress conditions. 22 Recently, the high-resolution structure of mammalian RyRs has been independently reported by several research groups. [30] [31] [32] [33] [34] The structure of RyR1-FKBP12 complex shows that that the BSol (HD2) domain binds to the SPRY2 domain of its neighbouring subunit, suggesting that the HD2 domain may play a role in coordinating the allosteric activity among RyR subunits. However, in FKBP-null RyR2, a large portion of HD2 is invisible, indicating that HD2 becomes flexible without FKBPs. Also, FKBP12.6-knockout mice chronically develop cardiac dysfunction due to the activation of a set of signalling cascades. 35 These new progresses re-arouse our interest on the role of FKBP12.6 in regulating RyR Ca 2þ release in cardiomyocytes. In the present study, we investigated the in situ role of FKBP12.6 in RyR function with a more rigorous experimental design. We compared the in situ behaviour of RyRs in wild-type and FKBP12.6 knockout cardiomyocytes, and provided direct evidence that FKBP12.6 does stabilize the in situ operation of RyRs in intact cardiomyocytes. FKBP12.6 loss-of-function and catecholamine stimulation synergistically over-sensitize the CICR, leading to arrhythmogenic intracellular Ca 2þ dynamics and ventricular arrhythmias.
Methods

Preparation of ventricular cardiomyocytes
The investigation conforms with the Guide for Care We measured the sparklet-spark latency only for the first spark triggered during a depolarization. The latency was determined by tracing back from the upstroke of a spark to the first datum point that fell below the SD of baseline. Given that the LCC-RyR coupling is a stochastic process, a significant portion of the latency data, represented by the first bar of the latency histogram, were too short for a sparklet to be visually identified (for example, see the right panel of Figure 3A ). However, this does not influence the reliability of the latency histogram, which follows an exponential distribution. The apparent rate constant (k) for RyRs to respond to LCC Ca 2þ sparklets was determined by fitting the , where N is the number of observations and N 0 is the N when t = 0.
Electrocardiography
Mice were lightly anesthetized with isoflurane (1%) and placed supine on a heated pad of 37 C. Needle ECG electrodes were placed under the skin to record from a Lead I configuration. After a 20-min baseline period, epinephrine (2 mg/kg) was injected intraperitoneally. Arrhythmias were defined as either non-sustained ventricular tachycardia (VT) (e.g. a series of 4-10 consecutive repetitive ventricular ectopic beats) or sustained VT (e.g. a run of 11 or more consecutive repetitive ventricular ectopic beats).
Data analysis and statistics
All data are expressed as mean ± SE unless otherwise indicated. The linear mixed effects model (by R program and lme4) or v 2 test, where appropriate, were applied for unpaired samples to determine statistical differences. Bonferroni correction was applied when more than two groups were compared to the same control. Curve fitting was performed using Sigmaplot software (Systat Software, Inc). Fitted data were compared using the u test. P < 0.05 was considered statistically significant.
Results
FKBP12.6-knockout increases LCC-RyR coupling fidelity
In order to test the effect of FKBP12.6 on the in situ RyR response to LCC Ca 2þ influx, we sought to trigger discrete Ca 2þ sparks by minimal LCC activation in ventricular cardiomyocytes from wild-type (WT) and FKBP12.6 knockout (FKO) mice. In cardiomyocytes loaded with the Ca 2þ indicator fluo-4, we recorded LCC Ca 2þ current (I LCC ) using the whole-cell patch clamp technique ( Figure 1A ). Neither the I LCC density ( Figure 1B ) nor its voltage dependence ( Figure 1C ) differed between WT and FKO. By Boltzmann fitting of the activation curves, we determined that the probability of LCC activation at -40 mV in both FKO and WT groups was only around 0.003 ( Figure 1C ). The low probability of LCC openings at the near-threshold depolarization allowed us to compare the frequency of solitary RyR Ca 2þ sparks triggered probabilistically by LCCs ( Figure 1D ). We found that the frequency of Ca 2þ sparks triggered by the depolarization from -50 to -40 mV was significantly higher in FKO than in WT ( Figure 1E ). Due to the low probability of LCC openings, the majority of Ca 2þ spark should be activated by a single LCC, confirming that the Ca 2þ influx through a single LCC is capable of triggering a Ca 2þ spark. 38 Because the I LCC at -40 mV (I -40 ), calculated based on Boltzmann fitting, was comparable between FKO and WT groups ( Figure  1F ), the higher frequency of Ca 2þ sparks in FKO reflected increased RyR response to LCCs. We therefore derived the LCC-RyR coupling fidelity by calculating the F spark per unit I -40 (F spark /I -40 , Figure 1G ), and found that the coupling fidelity was significantly higher in FKO than in WT. indicating that the SR load was not altered in FKO cells. It has been reported that the gain of excitation-contraction coupling is increased by early reverse Na þ /Ca 2þ exchange (NCX) activated during depolarization. 39 To avoid possible involvement of NCX, we applied minimal depolarization (from -50 to -40mV) when the Na þ channels were blocked by tetrodotoxin. Therefore, under our experimental conditions, the increased coupling fidelity in the FKO group was attributable to increased responsivity of RyRs to I LCC .
FK506 and rapamycin increases LCCRyR coupling fidelity in WT but not FKO cells
In heart cells, both FKBP12 and FKBP12.6 bind to RyRs but their binding affinity differs. 13, 40, 41 In order to check whether FKBP12 has a compensatory effect to FKBP12.6 knockout, we performed pharmacological experiments with 30 lmol/L FK506 and 10 lmol/L rapamycin, both are known to dissociate FKBPs from RyRs. 18, 19 Agreeing with previous reports, 19, 28, 42 neither FK506 nor rapamycin changed the I LCC (see Supplementary material online, Figure S1 ). We found that both FK506-and rapamycin-treatments increased the LCCRyR coupling fidelity (F spark /I LCC ) of WT cardiomyocytes to the same extent as that caused by FKO (comparing Figure 2A with Figure 1G ). In contract, neither treatment could further change the F spark /I LCC in FKO cells ( Figure 2B ), suggesting that FKBP12 did not exert a compensatory effect. The fact that FKBP12.6 knockout and FK506-/rapamycin-treatment have the same effect on F spark /I LCC indicated that the knockout-/ treatment-induced increase in RyR responsivity was fully attributable to FKBP12.6 dissociation.
FKBP12.6 absence accelerates RyR response to a single LCC
The whole-cell detection of Ca 2þ sparks usually involves out-of-focus events, and may also induce global feedback of CICR, particularly when the RyRs are sensitized. In order to further quantify the role of FKBP12.6 on LCC-RyR signalling, we visualized Ca 2þ sparklets from LCCs and triggered Ca 2þ sparks from RyRs by confocal imaging by loose-seal patch clamp. 37, 38 When the patched membrane was depolarized from resting potential (RP) to -10 mV, line-scan imaging focused at the pipette tip detected that Ca 2þ sparklets from LCCs (blue arrows in Figure 3A ) activated Ca 2þ sparks from RyRs (red arrows in Figure 3A ) in a stochastic manner. For those Ca 2þ sparklets that successfully triggered Ca 2þ sparks, the latency from the onset of an LCC sparklet to the takeoff of a triggered RyR spark varied, exhibiting exponential distributions in both WT and FKO groups ( Figure 3B ). The apparent rate constant (k) for RyRs to respond to LCC sparklets was then determined by fitting the distributions with the formula
where N is the number of observations and N 0 is the N when t = 0. The fitting showed that the k was 29% higher in FKO cells than in WT cells ( Figure 3C ), indicating that the LCC-RyR signalling was accelerated after FKBP12.6 knockout. In order to exclude any chronic compensatory effect of FKBP12.6 knockout, we further measured the LCC-RyR coupling latency with FK506 or rapamycin treatment in WT cardiomyocytes to acutely dissociate FKBP12.6 from RyR. Similarly with FKO cells, both FK506 and rapamycin accelerated LCC-RyR coupling rate ( Figure 3D-F 
b-adrenergic stimulation further accelerates RyR response to a single LCC in FKO cells
Next, we sought to probe whether the absence of FKBP12.6 influences the in situ RyR response to the stimulation of b-adrenergic receptors (bARs). In the whole-cell experiment, bAR stimulation will increase the LCC open probability, making it unreliable to quantify RyR response by near-threshold coupling fidelity (F spark /I LCC ). By the loose-patch activation of Ca 2þ sparks, we measured the coupling latency from LCC sparklets to RyR sparks when bARs was activated by 1 lmol/L isoproterenol (ISO, Figure 4A ). Normalized exponential fitting of the LCC-RyR latency distribution ( Figure 4B) showed that the LCC-RyR coupling latency was Figure 4C ). Because ISO and FKO alone increased the k by 33 and 29%, respectively, the 78% increase of k indicated that FKBP12.6 knockout and bAR stimulation additively sensitize the RyR response to Ca 2þ triggers.
Destabilization of CICR due to the absence of FKBP12.6
We then tested the stability of the CICR system at the whole-cell level by analysing intracellular Ca 2þ activity after 30 pulses of field stimulation To further test whether the cellular alterations described above predispose FKBP12.6 knockout mice to cardiac arrhythmias, we performed electrocardiography (ECG) in WT and FKO mice before and after catecholaminergic challenge by intraperitoneal administration of epinephrine (Epi) ( Figure 5C ). At basal condition, neither WT nor FKO displayed ventricular arrhythmias. Catecholaminergic challenge elicited few arrhythmic events in WT mice, but led to more frequent ventricular arrhythmias in FKO mice ( Figure 5D ).
Discussion
FK506-binding proteins, including FKBP12 and FKBP12.6, are important modulators of RyRs. 13, 43, 44 In heart cells, FKBP12.6 binds RyRs with a much higher affinity than FKBP12. 13, 40, 41, 45 In the present study, we investigated the role of FKBP12.6 in modulating RyR Ca 2þ release using FKBP12.6-knockout mice and FK506/rapamycin pharmacology. Either of these two experimental systems may have limitations: the acute treatment with FK506/rapamycin may contaminate with FKBP12 effect, while FKBP12.6-knockout strategy may involve chronic compensation. Therefore, we have exerted both experimental systems for complementary. The acute treatment with FK506/rapamycin excluded the chronic compensation and adaptation possibly associated with gene manipulation, but might involve an effect of FKBP12 dissociation. This latter concern was eliminated by the FKBP12.6 knockout results, which were fully attributable to the absence of FKBP12.6. Both lines of evidence demonstrated that FKBP12.6 dissociation (i) increased the CICR sensitivity and activation probability of RyRs, (ii) further sensitized RyRs under b-adrenergic stimulation, and (iii) elevated the risk for heart cells to develop arrhythmogenic Ca 2þ activity. Therefore, the presence of FKBP12.6
should play an important role in stabilizing the CICR system in intact heart cells. In previous studies, one of the problems keeping the role of FKBP12.6 from clarification is that RyRs are intracellular channels inaccessible to direct electrophysiological measurements. Although lipid bilayers have been widely used to study the interaction between FKBP12.6 and RyRs, the experimental settings vary greatly from lab to lab. For example, an experiment supporting FKBP12. 6 Figure S2 ). However, when the RyR Ca 2þ release was activated by native LCC current under the loose-patch and whole-cell depolarization conditions, we did find that the rate constant and probability of spark activation were significantly increased when FKBP12.6 was absent, presumably due to increased open probability of RyRs. These data indicated that the kinetic change of RyR activation is not reflected in spontaneous Ca 2þ sparks. The mixture of in-focus and off-focus Ca 2þ release events in spontaneous sparks makes it difficult to quantify RyR properties. Therefore, the difference in experimental design at least partially explains why the role of FKBP12.6 in stabilizing RyR Ca 2þ release is not detected in some studies.
In the present study, the triggering of RyR Ca 2þ sparks by unitary LCC current made it more feasible than previously to investigate RyR Ca 2þ -sensitivity in intact cells. Our LCC-RyR coupling experiments provided two lines of evidence for the enhanced Ca 2þ sensitivity of RyRs after FKBP12.6 knockout or FK506/rapamycin treatment: (i) an increased probability for LCC openings to activate RyRs, and (ii) an accelerated response of RyRs to single LCC Ca 2þ influx. Given that an LCC opening has limited lifetime, a quicker response implies that a RyR has a higher chance of being activated before the LCC closes. Therefore, the accelerated coupling kinetics agreed well with the increased probability of LCCRyR coupling. Both measurements provided unequivocal evidence that RyRs are sensitized to Ca 2þ triggers after FKBP12.6 dissociation. In other words, the sensitivity of RyR activation is under tonic suppression by FKBP12.6 under physiological conditions. Guo et al. 41 reported that only <20% FKBP12.6 binding sites on RyRs are occupied by FKBP12.6 in mouse heart cells. As each RyR has 4 FKBP12.6 binding sites on its 4 subunits, <41% RyRs would bind with one FKBP12.6 molecule, <15% with 2, <2.5% with 3, and only <0.16% RyRs would be fully occupied by FKBP12.6. The robust effect of FKBP12.6 knockout could not be explained if multiple FKBP12.6 binding was required to modify RyR behaviour. Therefore, we infer that single occupation of the FPBP12.6-binding sites should be effective in stabilizing RyR function. Based on the recent reports of RyR structure, [31] [32] [33] [34] FKBP is inserted into the gap between JSol (handle) domain and SPRY triangle. Structural comparison using the data of RyR1-FKBP12 complex 32 and FKBP-null RyR2 34 suggested that the insertion of FKBP may adjust the positioning of certain domains such that the BSol (HD2) domain can be anchored onto the SPRY2 domain of the neighbouring protomer (nSPRY2) ( Figure 6A and B) . The putative HD2-nSPRY2 interaction thus provides a possible mechanism for inter-subunit coordination ( Figure  6C ). In this scenario, a single-subunit occupation of FKBP12.6 would be expected to stabilize 2 adjacent subunits of a RyR, and a 20% occupation of FKBP12.6-binging sites would stabilize $59% (41 þ 15 þ 2.5 þ 0.16)% RyRs. This prediction explains the robust effect of FKBP12.6 knockout on LCC-RyR signalling. The role of FKBP12 in modulating RyRs in cardiac cells is another emerging controversy. It is shown that FKBP12 binds RyRs with very low affinity in heart cells, 41 and overexpression of FKBP12 reduces the sensitivity of RyRs to Ca 2þ . 46 However, it has been reported that FKBP12 is a high affinity activator of RyR2, sensitizing RyRs to cytosolic Ca 2þ . 47 In the present study, we showed that FK506 did not further influence coupling fidelity in FKBP12.6-null cardiomyocytes, suggesting that FK506-induced FKBP12 dissociation had little effects on RyR sensitivity in intact ventricular cardiomyocytes. The sympathetic system regulates heart function through ARs. It has been reported that FKBP12.6 knockout mice develop severe arrhythmia that leads to sudden cardiac death during exercise, well mimicking catecholaminergic polymorphic ventricular tachycardia. 24, 25 However, many experiments do not support the above idea. 17, 26, 27 It has been shown that FKBP12.6 knockout neither promotes RyR activity nor causes ventricular arrhythmias under stress conditions. 22 To determine whether and how FKBP12. 53 The results from FKBP12.6 overexpression mouse model and our FKBP12.6 knockout model double confirmed that FKBP12.6 exerts a protective effect on heart function. CICR is intrinsically a positive feedback loop, and would be expected to be explosive. 55 However, the Ca 2þ release of RyRs in heart cells is modulated precisely in the forms of both global Ca 2þ transients and local Ca 2þ sparks. As the key mechanism to avoid the self-excitation of CICR in heart cells, RyRs and LCCs are clustered to form discrete CRUs. 12, 56, 57 Within each CRU, the Ca 2þ influx through LCCs travels across a $15 nm junctional cleft, and activates RyRs in a stochastic manner. 58 Between CRUs, however, the longer distance prevents crosstalk between adjacent CRUs. 12 In this scenario, the RyR sensitivity must be limited within a certain dynamic range, or stability margin, such that the RyRs respond promptly to Ca 2þ signals from LCCs but not to those from adjacent CRUs. Based on our findings, b-AR stimulation and FKBP12.6 dissociation both sensitized RyRs. When either of these factors act solo, the chance of generating regenerative Ca 2þ activity is kept at a low level comparable with that in wild-type/control conditions, suggesting that moderate sensitization by FKBP12.6 dissociation per se was still within the stability margin of the CICR system. However, when both factors concur, the additive sensitization of RyRs causes chaotic Ca 2þ waves in most cells, indicating that the sensitization of RyRs have stepped beyond the stability margin of the CICR system. Once inter-CRU CICR is enabled due to over-sensitization of RyRs, the intracellular Ca 2þ release runs out-of-control, and Ca 2þ waves occur in a Figure 6 Structural comparison between RyR1-FKBP12 complex and FKBP-null RyR2. The images were generated based on the original structural data from Zalk et al. 32 for RyR1 and from Peng et al. 34 for RyR2. (A) In RyR1-FKBP12 complex, the JSol (HD2) domain potentially interacts with the SPRY2 domain of the neighbouring protomer (nSPRY2). (B) In FKBP-null RyR2, the HD2 domain is largely invisible, indicating that it may be floating without HD2-nSPRY2 interaction. (C) A hypothetic scheme based on the above information illustrating that the putative HD2-nSPRY2 interaction provides a possible mechanism for FKBPs to coordinate the allosteric activity among protomers. This HD2-nSPRY2 interaction may become destabilized without FKBP.
regenerative manner. The chaotic Ca 2þ waves not only prevent cardiomyocytes from rhythmic contraction and relaxation but also activate Na þ /Ca 2þ exchange and lead to arrhythmogenic excitation. 59 Therefore, preventing RyRs from the wave generation is a prerequisite for the healthy operation of heart cells. The FKBP12.6-mediated suppression of RyR sensitivity is a key mechanism to keep the CICR system from wave generation and cardiac arrhythmia, allowing an indispensable stability margin for dynamic regulation of blood pumping power.
Limitations
The constitutive FKBP12.6 knockout mouse model has limitations for this study, since the chronic knockout might bring adaptive or compensatory effect. Recently, it has been reported that aged FKBP12.6 knockout mice (1-year old) develop cardiac dysfunction due to the activation of the AKT/mTOR pathway. 35 Although the above activation has not been detected at the age of 3-month-old mice as the same age we used in the present study, we should be cautious that other adaptation might occur. Although we used FK506/rapamycin to acutely dissociate FKBP12.6 from RyRs in order to exclude any adaptive effect that might be brought about by the constitutive knockout of FKBP12.6, there was still limitation, because FK506/rapamycin also dissociates FKBP12. The perfect model for this study is cardiac-specific conditional FKBP12.6 knockout animal. Unfortunately, this model has not been available yet.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
